Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
ALTB-268-201 is a Phase 2a, multicenter, single arm, multiple-dose, open-label study evaluating the efficacy and safety of ALTB-268 in subjects with moderately to severely active UC. The study consists of a Screening Phase, an Induction Phase, a Maintenance Phase, and an OLE.
Sponsor: AltruBio Inc.
Check if you qualify for this ulcerative colitis clinical trial in Orlando, FL
If you're searching for ulcerative colitis treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.